Goldman Jonathan bought AVTX
November 14, 2025 · Form 4 insider transaction
Goldman Jonathan bought 8,200 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $81.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,200
Price
$9.88
Total value
$81.0K
InsiderGoldman Jonathan
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 14, 2025
Filing dateNovember 17, 2025
Shares owned after8,200
OwnershipDirect
10b5-1 planNo
AmendedNo